October 7, 2020
Sunovion Pharmaceuticals, a US subsidiary of Sumitomo Dainippon Pharma, said on October 5 that its apomorphine sublingual film Kynmobi (apomorphine) is now available in the US for the acute, intermittent treatment of “off” episodes in patients with Parkinson’s disease. Kynmobi...read more